Welcome to GenQA

**Details of GenQA's 2020 EQAs to be released soon - includes new EQAs**

Genomics Quality Assessment (GenQA) provides a quality assurance service for genomics through a broad consistent and sustainable range of relevant external quality assessments (EQAs) at a reasonable cost to the genomic community worldwide.

GenQA provides objective information and advice to laboratories and individuals on the quality of their analytical and interpretative performance in order to help them provide accurate and reliable test results and advice which ultimately facilitates optimal patient care.

Advances in our understanding of genomic medicine has led to a revolution in testing availability and GenQA is committed to providing external quality assessment in this rapidly evolving field.

Countries participating in EQA through GenQA

 

GenQA EQA specialities include:

(Click on each specialty for further information).

Molecular Genetic
Disorders

Variant 
Classification and Interpretation

Molecular
Pathology

Sample Handling 
(DNA extraction & DNA quantification)

Newborn
Screening

Preimplantation Genetic Testing
(PGT)

Haematological
Neoplasms

Technical
(Next Generation Sequencing)

Constitutional 
Postnatal Testing

Prenatal (including
Non-Invasive)
Testing

Clinical
Genetics

 Individual Competency Assessment (GTACT and Tissue-i)

From 1st January, 2018 Cytogenomics External Quality Assessment Service (CEQAS) and UK National External Quality Assessment Service (UK NEQAS) Molecular Genetics merged to become Genomics Quality Assessment (GenQA). GenQA is part of the UK NEQAS Consortium.

GenQA operates under the legal entity of OUH NHS Foundation Trust and is provided from two sites (Edinburgh and Oxford).

 

Last updated: Wednesday, 11 September 2019
Go to top